These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 32976026)
1. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel. Pau AK; Aberg J; Baker J; Belperio PS; Coopersmith C; Crew P; Grund B; Gulick RM; Harrison C; Kim A; Lane HC; Masur H; Sheikh V; Singh K; Yazdany J; Tebas P; Ann Intern Med; 2021 Jan; 174(1):93-95. PubMed ID: 32976026 [TBL] [Abstract][Full Text] [Related]
2. Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment. Lung T; Sakem B; Risch M; Nydegger U Transfus Apher Sci; 2021 Jun; 60(3):103108. PubMed ID: 33678561 [No Abstract] [Full Text] [Related]
3. Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019. Hartog N; Holsworth A; Rajasekaran S Ann Allergy Asthma Immunol; 2021 Feb; 126(2):122-123. PubMed ID: 33161152 [No Abstract] [Full Text] [Related]
4. Emergency Approvals for COVID-19: Evolving Impact on Obligations to Patients in Clinical Care and Research. Lynch HF; Bateman-House A; Joffe S Ann Intern Med; 2021 Feb; 174(2):256-257. PubMed ID: 33136427 [TBL] [Abstract][Full Text] [Related]
5. Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients. Franchini M; Casadevall A; Senefeld JW; Joyner MJ; Sullivan DJ; Focosi D Semin Thromb Hemost; 2024 Jun; 50(4):648-653. PubMed ID: 37984358 [No Abstract] [Full Text] [Related]
6. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection. Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411 [TBL] [Abstract][Full Text] [Related]
11. Thinking more about therapy with convalescent plasma for COVID-19 patients. Han G; Zhou YH Hum Vaccin Immunother; 2020 Nov; 16(11):2601-2603. PubMed ID: 32643512 [No Abstract] [Full Text] [Related]
12. Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying. Yoo JH J Korean Med Sci; 2020 Apr; 35(14):e150. PubMed ID: 32281318 [No Abstract] [Full Text] [Related]
13. Google Trends demonstrate public interest in COVID-19 convalescent plasma therapy. Adkins BD; Booth GS J Clin Apher; 2021 Jun; 36(3):492-493. PubMed ID: 33340373 [No Abstract] [Full Text] [Related]
14. Treatment of immunocompromised COVID-19 patients with convalescent plasma. Fung M; Nambiar A; Pandey S; Aldrich JM; Teraoka J; Freise C; Roberts J; Chandran S; Hays SR; Bainbridge E; DeVoe C; Roque Gardner A; Yokoe D; Henrich TJ; Babik JM; Chin-Hong P Transpl Infect Dis; 2021 Apr; 23(2):e13477. PubMed ID: 32989856 [TBL] [Abstract][Full Text] [Related]
18. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma. Vandeberg P; Cruz M; Diez JM; Merritt WK; Santos B; Trukawinski S; Wellhouse A; Jose M; Willis T Transfusion; 2021 Jun; 61(6):1705-1709. PubMed ID: 33715160 [TBL] [Abstract][Full Text] [Related]
19. Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study. Wu Y; Hong K; Ruan L; Yang X; Zhang J; Xu J; Pan S; Ren L; Chen L; Huang C; Shang Y Virol Sin; 2020 Dec; 35(6):768-775. PubMed ID: 32865701 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience. Fabricius MM; Dandachi D Mo Med; 2021; 118(1):74-80. PubMed ID: 33551490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]